The Influence of Risperidone on Cognitive Functions in Schizophrenia

Collegium Antropologicum

Volumn 27, Issue SUPPL. 1, 2003, Pages 111-118

  Barkić, Jelena ^a   Filaković, Pavo ^a   Radanović Grgurić, Ljiljana ^a   Koić, Oliver ^a   Laufer, Davor ^a   Požgain, Ivan ^a   Koić, Elvira ^b   Hotujac, Ljubomir ^c  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b General Hospital Virovitica   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Cognitine function; Risperidone; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; EVALUATION; HUMAN; INTELLIGENCE; MALE; MENTAL CAPACITY; PSYCHIATRIC TREATMENT; SCHIZOPHRENIA; SHORT TERM MEMORY; STATISTICAL SIGNIFICANCE; THINKING; MIDDLE AGED; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION; HUMANS; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 12144288134     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. SHORE, D., Shizophr. Bull., 23 (1997) 653.
2. -2. KEEFE, R. S. E., S. PERKINS, Shizophr. Bull., 25 (1999) 201.
3. KIRKPATRICK, B., A. KOPELOWICZ, R. W. BUCHANAN, W. T. CARPENTER, Neuropsychopharmacology, 22 (2000) 303.
4. -4. KEEFE, R. S. E., S. G. SILVA, D. O. PERKINS, J. A. LIEBERMAN, Schizophr. Bull., 25 (1999) 201.
5. -5. LAMBERG, L., J.A.M.A., 11 (1998) 280.
6. KEEFE, R. S. E., Psychiatric Annual, 29 (1999) 623.
7. -7. ASARNOW, R. F., K. H. NURCHTERLEIN, K. L. SUBOTNIK, D. L. FOGELSON, R. D. TORQUATO, D. L. PAYNE, J. ASAMEN, J. MINTZ, D. GUTHRIE, Arch. Gen. Psychiatry, 59 (2002) 1053.-
8. PARY, R., S. L. ARNP, P. R. MATUSCHKA, S. LIPPMAN, South. Med. J., 95 (2002) 743.
9. -9. CANNON, T. D., M. O. HUTTUNEN, M. DAHLSTRÖM, I. LARMO, P. RÄSÄNEN, A. JURILOO, Am. J. Psychiatry, 159 (2002) 1230.-
10. WEIDEN, P. J., R. AQUILA, L. DALHEIM, J. M. STANDARD, J. Clin. Psychiatry, 58 (1997) 63.
11. -11. MALLA, A. K., R. M. G. NORMAN, V. KOTTEDA, S. ZIRUL, Clinical Therapeutics, 21 (1999) 806.-
12. MASAND, S. P., S. L. BERRY, Ann. Pharmacother., 34 (2000) 200. -
13. GLICK, I. D., P. LEMMENS, E. VESTER-BLOKLAND, Int. Clin. Psychopharmacol, 16 (2001) 265.
14. -14. ANONYMOUS: Diagnostic and statistical manual of mental disorders (APA, Washington, 1994). -
15. GUY, W.: Early clinical drug evaluation program assessment manual for psychopharmacology. (US Dept of Health, Education and Welfare, Bethesda, 1976).
16. -16. KAY, S. R., A. FISZBEIN, L. A. OPLER, Schizophr. Bull., 13 (1987) 261. -
17. BURNS, T., J. P. CHABANNES, K. DEMYTTENAERE, Curr. Med. Res. Opin., 18 (2002) 201.
18. -18. ANONYMOUS: AB Priročnik za revidirani ARMY BETA inteligenični test. (Zavod SR Slovenije zavarstvo pri radu-Centar za psihologijo, medicino in tehnično varnost prometa, Ljubljana, 1977).
19. -19. DURIĆ, T., Ž. BELE-POTOČ-NIK, B. HRUŠEVAR.: Priručnik za test pažnje. (Zavod SR Slovenije za produktivnost dela, Centar za psihodijagnostična sredstva, Ljubljana, 1985). -
20. BENTON, A. L.: The revised visual retention test: Clinical and experimental application. (University of Iowa, 1963). -
21. MCGURK, S. R., M. F. GREEN, W. C. WIRSHING, D. AMES, B. D. MARSHALL, S. R. MARDER, CNS Spectrums, 2 (1997) 60. -
22. DESAI, N. M., Z. HUQ, S. D. MARTIN, G. MCDONALD, Advances in Therapy, 16 (1999) 78.
23. -23. SHERINGHAM, J.: Drug for side-effects in schizophrenia can cause memory problems too. (Winter Workship on Shizophrenia, 2000). -
24. STIP, E., Can. J. Psychiatry, 41 (1996) S27.
25. -25. ARANA, G. W., A. B. SANTOS.: Anticholinergics and amatadine. In: KAPLAN, H. I., B. J. SADOCK (Eds.): Comprehensive textbook of psychiatry. (Williamsand Wilkins, Baltimore, 1995). -
26. CHERNANSKY, J. G., R. MAHMOUD, R. BRENNER, N. Engl. J. Med., 346 (2002) 16.
27. -27. GREEN, M. F., B. D. Jr. MARSHALL, W. C. WIRSHING, D. AMES, S. R. MARDER, S. MCGURK Am. J. Psychiatry, 154 (1997) 799. -
28. SCHOTTE, A., P. F. JANSSEN, W. GOMMEREN, W. LUYTEN, P. VAN COMPEL, A. LESSAGE, Psychopharmacology (Berl.), 124 (1996) 57.
29. -29. ELLINGROD, V. L., S. K. SCHULTZ, K. EKSTAM-SMITH, E. KUTSCHER, C. TURVEY, S. ARNDT, Pharmacotherapy, 22 (2002) 1.
30. -30. CHAUDHRY, I. B., S. D. SONI, J. S. E. HELLWELL, J. F. W. DEAKIN, Schizophrenia Research, 53 (2002) 17. -
31. SUMIYOSHI, T., M. MATSUI, S. NOHARA, I. YAMASHITA, M. KURACHI, C. SUMIYOSHI, K. JAYATHILAKE, H. Y. MELTZER, Am. J. Psychiatry, 158 (2001) 1722.
32. -32. ROWLEY, M., L. J. BRISTOW, P. H. HUTSON, Journal of Medical Chemistry, 44 (2001) 477. -
33. KAPUR, S., P. SEEMAN, Am. J. Psychiatry, 158 (2001) 360.
34. -34. LEUCHT, S., G. PITSCHEL-WALZ, D. ABRAHAM, W. KISSLING, Schizophrenia Reseach, 35 (1999) 51.
35. -35. HONEY, G. D., PNAS, 96 (1999) 13432. -
36. CORNBLATT, B. A., T. LENCZ, J. M. KANE, Schizophr. Res., 51 (2001) 31.
37. -37. DAVID, A., Acta Psychiatrica Scandinavica, 100 (1999) 1.